How Long Can A Man Stay On Hormone Therapy For Prostate Cancer?

Hormone therapy is one of the main treatment options for men with prostate cancer. It works by lowering or blocking testosterone, which fuels the growth of prostate cancer cells. 

While it can be very effective, many men wonder how long they might need to stay on hormone therapy. The answer isn’t always straightforward, as the duration depends on the type of cancer, treatment goals, and individual health.

How does hormone therapy work for prostate cancer?

Hormone therapy, also called androgen deprivation therapy (ADT), aims to reduce testosterone levels. Testosterone helps prostate cancer cells grow, so blocking it slows or stops their spread. 

The two main approaches are medicines that reduce hormone production and surgery that removes the testicles (orchidectomy). Medicines are more commonly used today because they’re reversible, unlike surgery.

You might be prescribed injections, tablets, or a combination. These treatments lower testosterone to very low levels, which can shrink tumours and ease symptoms. Always consult with a doctor before starting or stopping any treatment.

When hormone therapy is recommended

Doctors usually suggest hormone therapy in specific cases. It may be offered if the cancer has spread beyond the prostate, if surgery or radiotherapy isn’t suitable, or if the cancer has come back after treatment. 

Sometimes it’s given alongside radiotherapy to increase effectiveness, especially for men with high-risk prostate cancer.

Hormone therapy might also be used to manage symptoms in advanced stages. By reducing testosterone, it can ease pain and slow disease progression. The decision depends on your diagnosis, overall health, and treatment goals.

How long can hormone therapy last?

The length of hormone therapy can vary widely. For some men, it’s given for a fixed time such as 6 months, 18 months, or 3 years, often alongside radiotherapy. For others, it may continue indefinitely if the cancer is advanced or has spread.

Doctors sometimes use intermittent therapy. This means treatment is given for a period, then stopped to allow testosterone to rise again. 

It can reduce side effects and improve quality of life, though it may not be suitable for everyone. Your specialist will guide you on whether continuous or intermittent treatment is best.

Factors that affect the duration

Several factors influence how long you’ll stay on hormone therapy:

  • Stage of cancer: Men with early-stage prostate cancer may only need short-term treatment, while those with advanced cancer may require long-term or lifelong therapy.
  • Other treatments: If hormone therapy is combined with radiotherapy, you might stay on it for a set period, often 2 to 3 years.
  • Response to treatment: If your PSA levels stay low and the cancer is controlled, your doctor may pause treatment under close monitoring.
  • Overall health: Pre-existing conditions and your ability to tolerate side effects also play a role.

Benefits of staying on hormone therapy

Hormone therapy may slow cancer progression, relieve symptoms, and extend survival. For men with advanced cancer, it’s often the most effective way to keep the disease under control for as long as possible. Combined with other treatments, it may also reduce the chance of the cancer returning.

Side effects to consider

Staying on hormone therapy for a long time does come with side effects. Because testosterone is important for many body functions, reducing it can cause hot flushes, fatigue, weight gain, reduced muscle mass, and low sex drive. It may also increase the risk of osteoporosis, heart problems, or diabetes.

It’s important to discuss side effects openly with your doctor, as they can suggest ways to manage them. Regular exercise, a healthy diet, and bone-strengthening medicines may help reduce risks. Always consult with a healthcare professional before making lifestyle or treatment changes.

Intermittent vs continuous hormone therapy

Doctors sometimes recommend intermittent therapy to give men breaks from side effects. During off-treatment periods, testosterone levels recover, which can improve energy and quality of life. 

However, not all men are suitable candidates, and some cancers respond better to continuous therapy. Your oncologist will assess whether intermittent treatment is safe and effective for you.

Quality of life considerations

While hormone therapy controls cancer, the impact on daily life can’t be overlooked. Fatigue, mood changes, and sexual side effects can affect wellbeing. Some men may prefer intermittent treatment to give their body breaks. 

Others choose continuous therapy for reassurance that the cancer is being held back. Talking openly with your healthcare team helps you find a balance that works for your health and lifestyle.

Monitoring during treatment

If you’re on hormone therapy, your doctor will monitor PSA levels, testosterone levels, and general health. Regular checks help track how well the treatment is working and whether adjustments are needed. 

Scans may also be done to check for cancer progression. Consistent monitoring ensures that therapy continues to provide the best possible benefit.

When treatment stops working

Unfortunately, some cancers stop responding to hormone therapy over time. This is called castration-resistant prostate cancer. 

When this happens, doctors may suggest other treatments such as chemotherapy, targeted medicines, or clinical trials. Even then, hormone therapy may still continue alongside other drugs to provide ongoing benefits.

Final notes

How long you’ll stay on hormone therapy for prostate cancer depends on many factors, including the stage of disease, response to treatment, and your personal preferences. Some men may only need it for a set time, while others may remain on it for many years. 

The most important step is to work closely with your healthcare team to find the right balance between controlling the cancer and maintaining quality of life. Always consult with a doctor or healthcare professional before making any treatment decisions.

Related guide: How To Check For Prostate Cancer At Home.

Picture of Maneesh Ghei
Maneesh Ghei
Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.
Scroll to Top